What is the NOAEL for Heparin sodium?
Heparin sodium has 84 NOAEL studies in the database. The lowest reported value is 12M44VTJ7B UNII. Source: openFDA substances.
NOAEL Data
Cosmetic Ingredient
Heparin sodium
Also known as: Heparin, sodium salt, Adomiparin sodium, Dalteparin sodium, Deligoparin sodium, Liquaemin sodium (+13 more)
CAS 9041-08-1
Heparin sodium (CAS 9041-08-1) is a chemical substance. Key regulatory status: 9 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS.
SOURCE
noael studies public
NOAEL studies
84
SOURCE
chemical inventory jurisdictions
Regulatory lists
9
SOURCE
eu clp annex vi
GHS signal
Not classified
Chemical Identity
CAS, identifiers, formula, and alternate names for the matched substance record.
SOURCE
DSSTox identifiers
21 fields
Name
Heparin sodium
CAS Number
9041-08-1
DTXSID
DTXSID301010914
Synonyms
Heparin, sodium saltAdomiparin sodiumDalteparin sodiumDeligoparin sodiumLiquaemin sodiumMinolteparin sodiumNadroparine sodiumNecuparanib sodiumParnaparin sodiumReviparin sodiumSemuloparin sodiumSevuparin sodium
Functional Uses
Industrial and product-use categories associated with this substance.
SOURCE
EPA CPDat
1 records
Softener and conditioner
Regulatory Lists
Inventory, screening, and regulatory list matches from public chemical databases.
SOURCE
EPA CPDat
9 records
| List | Keyword | Source |
|---|---|---|
| pharmaceutical | US International Trade Commission | CPCat |
| pharmaceutical | US International Trade Commission | CPCat |
| pharmaceutical | US International Trade Commission | CPCat |
| pharmaceutical | US International Trade Commission | CPCat |
| pharmaceutical | US International Trade Commission | CPCat |
| pharmaceutical | US International Trade Commission | CPCat |
| Canada; consumer_product; Substances in Products - Canada (4/2014) | Government of Canada | CPCat |
| Canada; consumer_product; Substances in Products - Canada (4/2014) | Government of Canada | CPCat |
| Canada; consumer_product; Substances in Products - Canada (4/2014) | Government of Canada | CPCat |
NOAEL Studies
Toxicology endpoints rendered from public NOAEL study rows.
SOURCE
NOAEL studies
Showing 50 of 84 studies
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 12M44VTJ7B | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 12M44VTJ7B | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 12M44VTJ7B | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 12M44VTJ7B | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 19GW9E1WHN | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 19GW9E1WHN | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 19GW9E1WHN | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 19GW9E1WHN | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3S182ET3UA | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3S182ET3UA | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3S182ET3UA | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3S182ET3UA | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 4UTY6300OM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 4UTY6300OM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 4UTY6300OM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 4UTY6300OM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 5XQ9UBJ16W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 5XQ9UBJ16W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 5XQ9UBJ16W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 5XQ9UBJ16W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 6DZH9J3B27 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 6DZH9J3B27 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 6DZH9J3B27 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 6DZH9J3B27 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N3927D01PB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N3927D01PB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N3927D01PB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N3927D01PB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N816FF9P2W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N816FF9P2W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N816FF9P2W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| N816FF9P2W | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| P59JKU02CE | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| P59JKU02CE | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| P59JKU02CE | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| P59JKU02CE | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R5MB4B485P | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R5MB4B485P | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R5MB4B485P | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R5MB4B485P | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| U6K360XMIU | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| U6K360XMIU | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| U6K360XMIU | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| U6K360XMIU | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| V5T10N50RD | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| V5T10N50RD | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| V5T10N50RD | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| V5T10N50RD | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| ZZ45AB24CA | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| ZZ45AB24CA | UNII | FDA UNII substance identifier | - | - | openFDA substances |
Showing 50 of 84 studies
Australian Status (AICIS)
Australian industrial chemicals inventory status and applicable conditions.
SOURCE
AICIS inventory
1 records
Inventory Status
listed
Cosmetic Safety Profile
Same-CAS cosmetic ingredient record for cross-vertical context.
SOURCE
CosIng / Ingredients DB
EU Status
permitted
Max
-
Category
Skin Conditioning
Pharmaceutical Data
Same-CAS pharmaceutical records from drug and bioactivity sources.
SOURCE
EMBL-EBI ChEMBL
bemiparin
ChEMBL Phase
Not listed
Adverse Events
3434
Bioactivity
0
Frequently Asked Questions
What regulatory lists include Heparin sodium?
Heparin sodium appears on 2 regulatory/inventory lists including pharmaceutical, Canada; consumer_product; Substances in Products - Canada (4/2014). Source: EPA CPDat.
Is Heparin sodium used in cosmetics?
Yes, Heparin sodium is also indexed as a cosmetic ingredient under the name Sodium Heparin. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Where does the safety data for Heparin sodium come from?
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Is Heparin sodium used outside industrial chemicals?
Heparin sodium also appears in cosmetics, pharmaceutical databases.